Journey Clinical

“I am now able to support my community of bilingual and bicultural Latinos with a modality that has been transformative in helping heal intergenerational wounds.” In celebration of Hispanic Heritage Month, we celebrate the outstanding work of our Latino therapists who are dedicated to fostering healing and connection within their communities. Erica Priscilla Sandoval, LCSW, AWA is an incredible member of our community who shares here about how Ketamine-Assisted Psychotherapy (KAP) has been a transformative tool for both her clients and her practice. Thank you, Erica, for the vital work that you do! This month, we recognize our member psychotherapists, like Erica, who are making a lasting impact by expanding access to innovative, evidence-based mental health care.

Today, on #WorldMentalHealthDay, we raise awareness and advocate for the millions living with mental health challenges worldwide. Mental illness is one of the most pressing public health crises of our time — as 1 in 5 U.S. adults experience mental illness each year, according to NAMI. Despite growing awareness, stigma remains a significant barrier for many. At Journey Clinical, we’re committed to expanding access to transformative, evidence-based treatments like Ketamine-Assisted Psychotherapy (KAP) to address this crisis. Our collaborative care model allows patients to work with their trusted psychotherapists, receive personalized treatment plans, and experience the highest quality of comprehensive care possible for better clinical outcomes. Today, and every day, we work to break the stigma and prioritize mental health for all.

“Through offering Ketamine-Assisted Psychotherapy (KAP), I’ve seen that ketamine has provided gentle entry for clients that could not otherwise tolerate trauma work.” Journey Clinical KAP Provider, Heidi Dalzell, PsyD, is one of the most active and valued contributors to our online members-only forum, where she consistently offers guidance, support, and expert advice to our community of over 2,500 psychotherapists. We sat down with her to discuss how she has integrated KAP in her practice for our latest member feature. Thank you, Heidi, for being such an integral part of our community! Learn more about Heidi’s practice in our latest Community Feature: https://lnkd.in/eDQ3YRsw

“To be able to break down those barriers to where someone can actually allow themselves to rest is monumental.” During our San Diego KAP Provider Panel, panelist L.J. Lumpkin III, LMFT shared how Ketamine-Assisted Psychotherapy (KAP) helped a client, and himself, to finally confront and release deeply suppressed emotions through vulnerability and trust. If you’re a licensed mental health professional looking to begin your own KAP practice with Journey Clinical, or a potential patient interested in learning more about KAP treatment, visit https://lnkd.in/e3T4cpbG

We're excited to announce that three Journey Clinical members will be speaking at Denver PsyCon this Friday! Our expert panel, featuring Erin Carpenter, LCSW, Sujatha Reddy LPC BC-TAM PAPT, and Dana McDowell, MA, LPC Ketamine-Assisted Psychotherapy Practitioner, will discuss the transformative impact of offering KAP within their private practices. They'll share insights on delivering KAP as psychotherapists, complementary therapeutic approaches, and real-life patient success stories. Don't miss out! Register for the conference through the link in our bio and use code JC25 for 25% off all tickets: https://lnkd.in/eC_rRGTX Journey Clinical is also sponsoring the PsyCon After Party at 14er Brewing & Beer Garden on Friday from 5-7:30 PM. Even if you're not attending the conference, Journey Clinical members are welcome to join—just RSVP via our forum. We look forward to seeing you there!

“We’re always updating our protocols with current research for evidence-based practices in mind, along with the interests of psychotherapists to expand access to the therapeutic settings they want to offer.” During our Los Angeles Ketamine-Assisted Psychotherapy (KAP) Panel, Journey Clinical Prescriber Operations Team member Katrina Olive discussed the measures that Journey Clinical’s medical team takes to support different modalities as more therapists are becoming interested in hosting group/retreat KAP sessions. In our patient-centered collaborative care model, our highly trained, in-house medical team takes on all medical responsibilities of KAP (patient eligibility, prescriptions, and outcome monitoring) while our member psychotherapists stay within their scope of practice. If you’re a licensed mental health professional looking to begin your own Ketamine-Assisted Psychotherapy (KAP) practice with Journey Clinical, or a potential patient interested in learning more about KAP treatment, visit https://lnkd.in/e3T4cpbG

Our Co-Founder & CEO, Jonathan Sabbagh, will be speaking as a panelist at The REAL Summit, an event designed to harness the power of conversation and community to improve mental health. Jonathan will be joined by fellow speakers Shelby Clark, Daniel Claussen, Lindsay Hoover, and moderator Lia Mix, LMFT, CPTR as they discuss the investment landscape within the field of psychedelics, and future applications in mental health care. Journey Clinical's decentralized model is helping expand access to Psychedelic-Assisted Psychotherapy across the U.S. Our collaborative care model connects a dedicated medical team, licensed psychotherapists and eligible patients, enabling the delivery of high quality mental healthcare at scale. You can register for the event here: https://lnkd.in/ghw5isNn

“Postpartum folks who are struggling with mental illness need a lot of support – and Ketamine-Assisted Psychotherapy (KAP) is one ally in that formulation of support.” During our recent Bay Area Collaborative Care Panel, Deva Collective Founder Melissa Whippo, LCSW, spoke about her experiences of supporting her postpartum patients with KAP. Melissa has spent a decade in service of women’s health at the UCSF School of Medicine and now works mostly with the postpartum population. If you’re a licensed mental health professional looking to begin your own KAP practice with Journey Clinical, or a potential patient interested in learning more about KAP treatment, visit https://lnkd.in/e3T4cpbG

Mark your calendars for this Saturday and join us for a community-focused conversation about Ketamine-Assisted Psychotherapy (KAP) at the Penn Psychedelics Collaborative’s PhilaDelic Conference! This engaging panel will feature experienced Journey Clinical KAP Providers, Stephanie Field, LCSW LCADC, Meredith Futernick-Gerak, LPC, ACS, CPAT, CBSP, Claudia Chika, LMSW, and Anabella Bergamasco, LCSW, who will share their personal journeys, insights, and lessons learned in developing their KAP offerings within their private practice. Whether you're new to KAP or looking to expand your practice, this guided conversation is a unique opportunity to connect, share, and learn from peers! Visit the conference registration page here and apply code PHILLYPD24 for 30% off all conference passes: https://lnkd.in/dqasRaWS We can’t wait to see you there!

As September comes to a close, we want to commemorate World Suicide Prevention Month – a time to raise awareness, break the stigma, and extend support to those who may be struggling. According to NAMI, 46% of people who die by suicide had a diagnosed mental health condition — but research suggests that 90% may have experienced symptoms of a mental health condition. Journal Clinical’s mission is to expand access to innovative, evidence-based mental health treatments to millions of people across the U.S. Many of our KAP providers, like Meredith Futernick-Gerak, LPC, ACS, CPAT, CBSP work with patients that struggle with hard-to-treat conditions, such as treatment-resistant depression and C-PTSD. This month, we thank them for the incredible work that they do within their communities.